Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NantOmics

NantOmics
2012 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$251M LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of personalized molecular services designed to detect genomic and proteomic alterations in cancer. The company's molecular diagnostics approach combines DNA sequencing, RNA sequencing and quantitative proteomics to unearth the genomic and proteomic variances that initiate and drive cancer, by analysing both normal and tumour cells, enabling cancer patients to access personalized point of care.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 9920 Jefferson Street
  • Culver City, CA 90232
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NantOmics’s full profile, request a free trial.

NantOmics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 18-Sep-2015 $251M 00000 Completed Startup
1. Early Stage VC 15-Jan-2015 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NantOmics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personal Genome Diagnostics Venture Capital-Backed Baltimore, MD 000 00000 0000000000 0 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000000 00000000 Venture Capital-Backed Farmington, CT 0 00.000 00000000000 00.000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
To view this company’s complete list of competitors, request access »

NantOmics Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000000 13-Apr-2017 000000000000000000 Biotechnology 0000000 0000-000000 00
00000 00000000 02-Nov-2016 000000000 00000000 000 Biotechnology 0000000 0000-000000 00
00000000 000000000 10-Sep-2015 000000000000000000 Diagnostic Equipment 0000000 0000-000000 00
OncoPlex Diagnostics 01-Jan-2008 Later Stage VC 0000 Diagnostic Equipment 0000000 0000-000000 00
To view this company’s complete investment and acquisition history, request access »

NantOmics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
California Capital Equity PE/Buyout Minority 000 0000 000000 0
Relay Ventures Venture Capital Minority 000 0000 000000 0

NantOmics Executive Team (3)

Name Title Board
Seat
Contact
Info
Shahrooz Rabizadeh Ph.D Chief Scientific Officer
Patrick Soon-Shiong MD Founder & Chief Executive Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »